News › Industry News, State Laws

A telehealth website sold patients obesity drugs at affordable rates. Now they’re paying the price

February 11, 2025

Patients in Florida purchased three-month supplies of compounded tirzepatide from a telehealth provider. The compounding pharmacy that filled their prescriptions was found not to have a sterile compounding license, making thousands of dollars in medication potentially unsafe and at risk of contamination.

The Florida Department of Public Health filed a complaint against the compounding pharmacy, claiming that it was compounding without a sterile compounding license, improperly storing medicines that needed to be refrigerated and failing to document drugs it dispensed. Lack of this license is a violation of state license law.

Patients should be informed of which pharmacy is filling their prescriptions and know that patient counseling is available from licensed pharmacies in Florida.

Read more at NPR >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Galderma Celebrates 30 Years of Restylane
    • FDA Issues Letter to Evolus Over Jeuveau Social Media Promotion
    • North Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Retatrutide Phase 3 Trial: Adults With Type 2 Diabetes Lost Average of 50 Pounds
    • Medical Marketing Whiz Recognized With Healthcare Digital Marketing Excellence Award
Advertisement